Literature DB >> 29736264

Clinical management of Friedreich's Ataxia: a report of two cases.

Yannis Dionyssiotis1,2, Athina Kapsokoulou3, Anna Danopoulou2, Maria Kokolaki4, Athina Vadalouka4.   

Abstract

INTRODUCTION: Friedreich's ataxia (FDRA) is the most common autosomal recessive, early-onset ataxia. FDRA is a progressive neurodegenerative disease that mainly affects the posterior (dorsal) columns of the spinal cord resulting in sensory ataxia. It manifests in initial symptoms of poor coordination and gait disturbance. CASE
PRESENTATION: We present two cases, a brother (54 years old) and sister (56 years old), with FDRA that are chronically institutionalized for incomplete quadriplegia without spasticity. Gait and postural ataxia, cerebellar dysarthria, oculomotor dysfunction, musculoskeletal deformities, hearing impairment, hypertrophic cardiomyopathy, and diabetes mellitus are also present. Neurological examination reveals extensor plantar responses and diminished to absent tendon reflexes. Both are wheelchair bound, cannot perform daily tasks and need assistance. DISCUSSION: Although there is no cure that can alter the natural course of the disease physiotherapy, management of spasticity and neuropathic pain, symptomatic treatment of heart failure and diabetes and nursing care can grant the patients quality of life.

Entities:  

Year:  2018        PMID: 29736264      PMCID: PMC5920041          DOI: 10.1038/s41394-018-0071-x

Source DB:  PubMed          Journal:  Spinal Cord Ser Cases        ISSN: 2058-6124


  13 in total

1.  Clinical management of spasticity.

Authors:  A J Thompson; L Jarrett; L Lockley; J Marsden; V L Stevenson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

Review 2.  Friedreich's ataxia: pathology, pathogenesis, and molecular genetics.

Authors:  Arnulf H Koeppen
Journal:  J Neurol Sci       Date:  2011-04-15       Impact factor: 3.181

3.  Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations.

Authors:  M Cossée; M Schmitt; V Campuzano; L Reutenauer; C Moutou; J L Mandel; M Koenig
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

4.  Gait and balance in adults with Friedreich's ataxia.

Authors:  Jeannie Stephenson; Theresa Zesiewicz; Clifton Gooch; Lynn Wecker; Kelly Sullivan; Israt Jahan; Seok Hun Kim
Journal:  Gait Posture       Date:  2015-01-08       Impact factor: 2.840

5.  [Differential diagnosis of Friedreich ataxia].

Authors:  D Claus
Journal:  Nervenarzt       Date:  1989-01       Impact factor: 1.214

6.  Mortality in Friedreich ataxia.

Authors:  Amy Y Tsou; Erin K Paulsen; Sarah J Lagedrost; Susan L Perlman; Katherine D Mathews; George R Wilmot; Bernard Ravina; Arnulf H Koeppen; David R Lynch
Journal:  J Neurol Sci       Date:  2011-06-08       Impact factor: 3.181

Review 7.  Clinical features of Friedreich's ataxia: classical and atypical phenotypes.

Authors:  Michael H Parkinson; Sylvia Boesch; Wolfgang Nachbauer; Caterina Mariotti; Paola Giunti
Journal:  J Neurochem       Date:  2013-08       Impact factor: 5.372

Review 8.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

Review 9.  Friedreich's ataxia: clinical aspects and pathogenesis.

Authors:  M Pandolfo
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

Review 10.  Consensus clinical management guidelines for Friedreich ataxia.

Authors:  Louise A Corben; David Lynch; Massimo Pandolfo; Jörg B Schulz; Martin B Delatycki
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

View more
  1 in total

1.  Polyuria and Acute Hyperglycemia Secondary to New-Onset Diabetes in a Young Woman With Friedreich's Ataxia.

Authors:  Jasmine Santos; Jason R Woloski; Natasha Wu
Journal:  Cureus       Date:  2021-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.